Diagnosis and management of acute movement disorders

Journal of Neurology

Volumn 252, Issue 11, 2005, Pages 1299-1306

  Dressler, Dirk ^a   Benecke, Reiner ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Acute dystonic reaction; Akathisia; Dopamine; Drug induced; Episodic ataxias; Movement disorders; Neuroleptic malignant syndrome; Paroxysmal dyskinesias; Receptor blockade

Indexed keywords

ACETAZOLAMIDE; AMANTADINE; AMOXAPINE; ANTIEMETIC AGENT; APOMORPHINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZAMIDE DERIVATIVE; BENZATROPINE; BIPERIDEN; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLONIDINE; CLOZAPINE; CREATININE; DANTROLENE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPHENAZINE; HALOPERIDOL; LEVODOPA; LISURIDE; LITHIUM; METOCLOPRAMIDE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; UNINDEXED DRUG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AKATHISIA; ATAXIA; ATHETOSIS; AUTONOMIC DYSFUNCTION; BABINSKI REFLEX; BODY POSTURE; BRADYKINESIA; CHOREA; CHOREOATHETOSIS; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CREATININE BLOOD LEVEL; DELUSION; DIAGNOSTIC VALUE; DIAPHORESIS; DRUG SAFETY; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; EYE DISEASE; GAZE PARALYSIS; HEADACHE; HEMIBALLISM; HEREDITARY EPISODIC ATAXIA TYPE 1; HEREDITARY EPISODIC ATAXIA TYPE 2; HUMAN; HYPERTHERMIA; HYPERVENTILATION; HYPNOGENIC PAROXYSMAL DYSKINESIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOREFLEXIA; INFANTILE PAROXYSMAL DYSTONIA; MALAISE; MEMORY DISORDER; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; MYOCLONUS; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; NYSTAGMUS; OCULOGYRIC CRISIS; PARKINSONISM; PAROXYSMAL EXERTIONAL DYSKINESIA; PAROXYSMAL KINESIGENIC DYSKINESIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PSYCHOSIS; RESTLESSNESS; REVIEW; RHABDOMYOLYSIS; SANDIFER SYNDROME; SEIZURE; SIDE EFFECT; STARTLE REFLEX; TACHYCARDIA; TIC; TORTICOLLIS; TREATMENT OUTCOME; TREMOR; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MOVEMENT DISORDERS;

EID: 28144455332     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0006-x     Document Type: Review

References (70)

1. Addonizio G, Susman VL, Roth SD (1987) Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry 22:1004-1020
2. Akman-Demir FG, Eraksoy M, Gurvit IH, Saruhan-Direskeneli G, Aral O (1995) Paroxysmal dysarthria and ataxia in a patient with Behcet's disease. J Neurol 242:344-347
3. Angelini L, Rumi V, Lamperti E, Nardocci N (1988) Transient paroxysmal dystonia in infancy. Neuropediatrics 19:171-174
4. Auburger G, Ratzlaff T, Lunkes A, Nelles HW, Leube B, Binkofski F, Kugel H, Heindel W, Seitz R, Benecke R, Witte OW, Voit T (1996) A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 31:90-94
5. Ayd FJ Jr (1961) A survey of drug-induced extrapyramidal reactions. JAMA 175:1054-1060
6. Bain PG, Larkin GB, Calver DM, O'Brien MD (1991) Persistent superior oblique paresis as a manifestation of familial periodic cerebellar ataxia. Br J Ophthalmol 75:619-621
7. Bain PG, O'Brien MD, Keevil SF, Porter DA (1992) Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol 31:147-154
8. Baron DN, Dent CE, Harris H, Hart EW, Jepson JB (1956) Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features. Lancet 271(6940): 421-428
9. Bateman DN, Darling WM, Boys R, Rawlins MD (1989) Extrapyramidal reactions to metoclopramide and prochlorperazine. Q J Med 264:307-311
10. Berardi D, Amore M, Keck PE Jr, Troia M, Dell'Atti M (1998) Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case control study. Biol Psychiatry 44:748-754
11. Blaisdell GD (1994) Akathisia: a comprehensive review and treatment summary. Pharmacopsychiatry 27:139-146
12. Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423-432
13. Boyer WF, Bakalar NH, Lake CR (1987) Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactions. J Clin Psychopharmacol 7: 164-166
14. Braude WM, Barnes TR, Gore SM (1983) Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry 143:139-150
15. Brody AL (1996) Acute dystonia induced by rapid increase in risperidone dosage. J Clin Psychopharmacol 16:461-462
16. Caroff SN, Mann SC (1993) Neuroleptic malignant syndrome. Med Clin North Am 77:185-202
17. Chong SA, Tan CH (1996) Fluvoxamine and akathisia. J Clin Psychopharmacol 16:334-335
18. Dancis J, Hutzler J, Rokkones T (1967) Intermittent branched-chain ketonuria. Variant of maple-syrup-urine disease. N Engl J Med 276:84-89
19. Daras M, Koppel BS, Atos-Radzion E (1994) Cocaine-induced choreoathetoid movements ('crack dancing'). Neurology 44:751-752
20. Delay J, Pichot P, Lemperiere T, Elissade B, Peigne F (1960) Un neuroleptique majeur non-phenothiazine et non reserpinique, l'haloperidol, dans le traitement des psychoses. Annales Medico-Psychologique 118:145-152
21. Demirkiran M, Jankovic J (1995) Paroxysmal dyskinesias: Clinical features and classification. Ann Neurol 38:571-579
22. Dickey W (1991) The neuroleptic malignant syndrome. Prog Neurobiol 36:425-436
23. Duvoisin RC, Yahr MD (1965) Encephalitis and Parkinsonism. Arch Neurol 12:227-239
24. Fahn S (1994) The paroxysmal dyskinesias. In: Marsden CD, Fahn S (eds) Movement Disorders 3. Butterworth-Heinemann, Oxford, pp 310-345
25. Fink JK, Rainer S, Wilkowski J, Jones SM, Kume A, Hedera P, Albin R, Mathay J, Girbach L, Varvil T, Otterud B, Leppert M (1996) Paroxysmal dystonic choreoathetosis: tight linkage to chromosome 2q. Am J Hum Genet 59:140-145
26. Fouad GT, Servidei S, Durcan S, Bertini E, Ptacek LJ (1996) A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet 59:135-139
27. Gancher ST, Nutt JG (1986) Autosomal dominant episodic ataxia: a heterogeneous syndrome. Mov Disord 1:239-253
28. Garver DL, Davis DM, Dekirmenjian H, Ericksen S, Gosenfeld L, Haraszti J (1976) Dystonic reactions following neuroleptics: time course and proposed mechanisms. Psychopharmacologia 47:199-201
29. Gibb WR, Lees AJ (1986) The clinical phenomenon of akathisia. J Neurol Neurosurg Psychiatry 49:861-866
30. Gill J, Singh H, Nugent K (2003) Acute lithium intoxication and neuroleptic malignant syndrome. Pharmacotherapy 23:811-815
31. Gorard DA, Gibberd FB (1989) Paroxysmal dysarthria and ataxia: associated MRI abnormality. J Neurol Neurosurg Psychiatry 52:1444-1445
32. Gowers WR (1885) Epilepsy and Other Chronic Convulsive Diseases. Their Cause, Symptoms, and Treatment. Dover, New York (reprint of 1885 edition), 1964:75-76
33. Homan RW, Vasko MR, Blaw M (1980) Phenytoin plasma concentrations in paroxysmal kinesigenic choreoathetosis. Neurology 30:673-676
34. Horner FH, Jackson LC (1969) Familial paroxysmal choreoathetosis. In: Barbeau A, Brunette JR (eds) Progress in Neuro-Genetics. Excerpta Medica Foundation, Amsterdam, pp 745-751
35. Kastrup O, Gastpar M, Schwarz M (1994) Acute dystonia due to clozapine. J Neurol Neurosurg Psychiatry 57:119
36. Kertesz A (1967) Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology 17:680-690
37. Lance JW (1977) Familial paroxysmal dystonic choreoathetosis and its differentiation from related syndromes. Ann Neurol 2:285-293
38. Lang AE, Johnson K (1987) Akathisia in idiopathic Parkinson's disease. Neurology 37:477-481
39. Litt M, Kramer P, Browne D, Gancher S, Brunt ER, Root D, Phromchotikul T, Dubay CJ, Nutt J (1994) A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am J Hum Genet 55:702-709
40. Lopez-Alemany M, Ferrer-Tuset C, Bernacer-Alpera B (1997) Akathisia and acute dystonia induced by sumatriptan. J Neurol 244:131-132
41. Lugaresi E, Cirignotta F (1981) Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome? Sleep 4:129-138
42. Lugaresi E, Cirignotta F, Montagna P (1986) Nocturnal paroxysmal dystonia. J Neurol Neurosurg Psychiatry 49:375-380
43. Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10:55-72
44. Mazurek MF, Rosebush PI (1996) Circadian pattern of acute, neuroleptic-induced dystonic reactions. Am J Psychiatry 153:708-710
45. Miller CH, Hummer M, Oberbauer H, Kurzthaler I, DeCol C, Fleischhacker WW (1997) Risk factors for the development of neuroleptic induced akathisia. Eur Neuropsychopharmacol 7:51-55
46. Mount LA, Reback S (1940) Familial paroxysmal choreoathetosis. Arch Neurol Psychiat 44:841-847
47. Nonino F, Campomori A (1999) Neuroleptic malignant syndrome associated with metoclopramide. Ann Pharmacother 33:644-645
48. Plant G (1983) Focal paroxysmal kinesigenic choreoathetosis. J Neurol Neurosurg Psychiatry 46:345-348
49. Poyurovsky M, Meerovich I, Weizman A (1995) Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient. Int Clin Psychopharmacol 10:111-114
50. Raja M, Azzoni A (2001) Novel antipsychotics and acute dystonic reactions. Int J Neuropsychopharmacol 4:393-397
51. Rosenberg MR, Green M (1989) Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med 149:1927-1931
52. Rupniak NM, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl) 88:403-419
53. Sachdev P, Kruk J (1994) Clinical characteristics and predisposing factors in acute drug-induced akathisia. Arch Gen Psychiatry 51:963-974
54. Sakkas P, Davis JM, Janicak PG, Wang ZY (1991) Drug treatment of the neuroleptic malignant syndrome. Psychopharmacol Bull 27:381-384
55. Shahnawaz M, van der Westhuizen LR, Gledhill RF (2001) Episodic cervical dystonia associated with gastro-oesophageal reflux. A case of adult-onset Sandifer syndrome. Clin Neurol Neurosurg 103:212-215
56. Shalev A, Hermesh H, Munitz H (1988) The role of external heat load in triggering the neuroleptic malignant syndrome. Am J Psychiatry 145:110-111
57. Shen WW (1981) Akathisia: an overlooked, distressing, but treatable condition. J Nerv Ment Dis 169:599-600
58. Sicard JA (1923) Akathisia and tasikinesia. Presse Med (Paris) 31:265-266
59. Simpson GM, Lindenmayer JP (1997) Extrapyramidal symptoms in patients treated with risperidone. J Clin Psychopharmacol 17:194-201
60. Snyder CH (1969) Paroxysmal torticollis in infancy. Am J Dis Child 117:458-460
61. Susman VL, Addonizio G (1988) Recurrence of neuroleptic malignant syndrome. J Nerv Ment Dis 176:234-241
62. Swett C Jr (1975) Drug-induced dystonia. Am J Psychiatry 132:532-534
63. Thornberg SA, Ereshefsky L (1993) Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy 13:510-514
64. Vaamonde J, Artieda J, Obeso JA (1991) Hereditary paroxysmal ataxia with neuromyotonia. Mov Disord 6:180-182
65. Velamoor VR, Norman RM, Caroff SN, Mann SC, Sullivan KA, Antelo RE (1994) Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 182:168-173
66. Von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE (1995) Mapping the gene for acetazolamide responsive hereditary paroxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet 4:279-284
67. Wang HC, Hsieh Y (2001) Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy. Mov Disord 16:765-767
68. Washington C, Haines KA, Tam CW (1989) Amoxapine-induced neuroleptic malignant syndrome. DICP 23:713
69. Weiner WJ, Lang AE (1989) Movement Disorders: A Comprehensive Survey. Futura Publishing, Mout Kisco, New York, pp 582-583
70. Weller M, Kornhuber J (1992) A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome. Med Hypotheses 38:329-333